Status:
COMPLETED
Noninvasive Skin Spectroscopy for Diabetes Screening
Lead Sponsor:
InLight Solutions
Collaborating Sponsors:
VeraLight, Inc.
Conditions:
Prediabetic State
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to assess the performance of a noninvasive device for the early screening of Diabetes Mellitus.
Detailed Description
Approximately 18 million people have Type II diabetes, and of these, an estimated thirty-five percent are unaware of their condition. This translates to roughly 6.3 million undiagnosed cases worldwide...
Eligibility Criteria
Inclusion
- Volunteers without Diabetes.
- Volunteers at risk for developing Type II diabetes.
- 18 years of age and older.
Exclusion
- Under 18 years of age.
- Those diagnosed with Diabetes.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00358254
Start Date
October 1 2004
End Date
December 1 2007
Last Update
July 22 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
InLight Solutions
Albuquerque, New Mexico, United States, 87106
2
Tricore Reference Laboratory- Presbyterian Professional Building
Albuquerque, New Mexico, United States, 87106